We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,059 hedge funds and large institutions have $32.4B invested in Idexx Laboratories in 2023 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 384 increasing their positions, 385 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.1% more ownership

Funds ownership: 88.05%89.15% (+1.1%)

3% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 86

0% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 385

1% less funds holding

Funds holding: 1,0681,059 (-9)

12% less capital invested

Capital invested by funds: $36.7B → $32.4B (-$4.32B)

16% less funds holding in top 10

Funds holding in top 10: 2521 (-4)

20% less call options, than puts

Call options by funds: $86.1M | Put options by funds: $107M

Holders
1,059
Holders Change
-9
Holders Change %
-0.84%
% of All Funds
16.78%
Holding in Top 10
21
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16%
% of All Funds
0.33%
New
89
Increased
384
Reduced
385
Closed
86
Calls
$86.1M
Puts
$107M
Net Calls
-$21.2M
Net Calls Change
-$56.3M

IDXX Hedge Fund Activity: Q3 2023 in Review

1,059 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2023, worth a combined $32.4B — down 12% from $36.7B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new IDXX positions and 86 closed out — a net gain of 3 holders — while 384 added to existing stakes and 385 trimmed.

The largest buyer was GQG Partners, opening a new position worth an estimated $465M. The largest seller was AllianceBernstein, cutting an estimated $133M.

  • 1,059 institutional investors held Idexx Laboratories (IDXX) as of Q3 2023, down from 1,068 in Q2 2023.
  • Funds reported $32.4B of Idexx Laboratories stock for Q3 2023, down 12% quarter-over-quarter.
  • 89 funds opened new Idexx Laboratories positions in Q3 2023 and 86 closed out, a net change of +3 holders.
  • The largest Idexx Laboratories buyer in Q3 2023 was GQG Partners, an estimated $465M added.
  • The largest Idexx Laboratories seller in Q3 2023 was AllianceBernstein, an estimated $133M sold.

Based on aggregated 13F filings for Q3 2023.